Status:
UNKNOWN
Perioperative Epidural Anesthesia and Analgesia on Gut Microbiota
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Living Donor Hepatectomy
Eligibility:
All Genders
20-55 years
Phase:
NA
Brief Summary
As the only curative treatment for end-stage liver diseases, liver transplantation has been widely carried out around the world. The shortage of organs from deceased donors facilitate the adoption of ...
Eligibility Criteria
Inclusion
- Expected to receive living liver hepatectomy in National Taiwan University Hospital, age between 20 and 55 years old.
Exclusion
- Previous use of antibiotics within four weeks.
- Previous gastrointestinal surgery.
Key Trial Info
Start Date :
October 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04079673
Start Date
October 19 2019
End Date
July 31 2022
Last Update
October 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology, National Taiwan University Hospital
Taipei, Taiwan, 100